CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Jusvinza in rheumatoid arthritis	20/04/2022	Registered
Nasal recombinant human interferon alfa-2b in ARI	06/12/2022	Registered
Nasalferon in ARI	29/07/2022	Registered
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock	06/07/2023	Registered
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III	24/04/2023	Registered
BACONAO Study	12/11/2021	Registered outdated
ESPERANZA study	14/04/2020	Registered outdated
CIGB 2020 in contacts and SARS-CoV-2 infection suspects	13/04/2020	Registered outdated
Expanded Clinical Use of Nasalferon in COVID-19	10/11/2021	Registered outdated
HEBERFERON in renal cell carcinoma	05/01/2017	Registered outdated
CENTAURO-4 Study	30/04/2017	Registered outdated
Transfer factor in Chronic Kidney Disease	06/08/2020	Registered outdated
HeberNasvac® Phase IV in Chronic Hepatitis B	03/08/2018	Registered outdated
DENIS Study	22/10/2018	Registered outdated
EGF in bilateral symmetric diabetic neuropathy	23/03/2020	Registered outdated
AMIGOS-2 study	07/08/2018	Registered outdated
CERVICONC-II-300 study	07/08/2018	Registered outdated
COURAGE-2 Study	14/03/2019	Registered outdated
ATENEA-Co-300 study	28/05/2020	Registered outdated
AVATAR-2020	01/03/2021	Registered outdated